Zimmer Biomet Holdings Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 36/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 103.16.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Zimmer Biomet Holdings Inc's Score
Industry at a Glance
Industry Ranking
36 / 207
Overall Ranking
108 / 4560
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
30
analysts
Hold
Current Rating
103.158
Target Price
+11.22%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Zimmer Biomet Holdings Inc Highlights
StrengthsRisks
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 7.68B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.51%.
Undervalued
The company’s latest PE is 22.40, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 195.45M shares, decreasing 0.31% quarter-over-quarter.
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Ticker SymbolZBH
CompanyZimmer Biomet Holdings Inc
CEOTornos (Ivan)
Websitehttps://www.zimmerbiomet.com/en
FAQs
What is the current price of Zimmer Biomet Holdings Inc (ZBH)?
The current price of Zimmer Biomet Holdings Inc (ZBH) is 90.805.
What is the symbol of Zimmer Biomet Holdings Inc?
The ticker symbol of Zimmer Biomet Holdings Inc is ZBH.
What is the 52-week high of Zimmer Biomet Holdings Inc?
The 52-week high of Zimmer Biomet Holdings Inc is 114.440.
What is the 52-week low of Zimmer Biomet Holdings Inc?
The 52-week low of Zimmer Biomet Holdings Inc is 85.330.
What is the market capitalization of Zimmer Biomet Holdings Inc?
The market capitalization of Zimmer Biomet Holdings Inc is 18.00B.
What is the net income of Zimmer Biomet Holdings Inc?
The net income of Zimmer Biomet Holdings Inc is 903.80M.
Is Zimmer Biomet Holdings Inc (ZBH) currently rated as Buy, Hold, or Sell?
According to analysts, Zimmer Biomet Holdings Inc (ZBH) has an overall rating of Hold, with a price target of 103.158.
What is the Earnings Per Share (EPS TTM) of Zimmer Biomet Holdings Inc (ZBH)?
The Earnings Per Share (EPS TTM) of Zimmer Biomet Holdings Inc (ZBH) is 4.053.